KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bausch Health Companies (BHC) Tax Provisions (2016 - 2026)

Bausch Health Companies' Tax Provisions history spans 18 years, with the latest figure at $77.0 million for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 97.44% to $77.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $285.0 million, a 5.56% increase, with the full-year FY2025 number at $247.0 million, up 3.35% from a year prior.
  • Tax Provisions hit $77.0 million in Q1 2026 for Bausch Health Companies, down from $159.0 million in the prior quarter.
  • Over the last five years, Tax Provisions for BHC hit a ceiling of $159.0 million in Q4 2025 and a floor of -$16.0 million in Q1 2022.
  • Historically, Tax Provisions has averaged $51.0 million across 5 years, with a median of $49.0 million in 2024.
  • Biggest five-year swings in Tax Provisions: tumbled 200.0% in 2022 and later skyrocketed 556.25% in 2023.
  • Tracing BHC's Tax Provisions over 5 years: stood at $53.0 million in 2022, then fell by 24.53% to $40.0 million in 2023, then surged by 177.5% to $111.0 million in 2024, then surged by 43.24% to $159.0 million in 2025, then plummeted by 51.57% to $77.0 million in 2026.
  • Business Quant data shows Tax Provisions for BHC at $77.0 million in Q1 2026, $159.0 million in Q4 2025, and $37.0 million in Q3 2025.